Bukwang Pharmaceutical (003000) is showing a sharp rise in the afternoon session on the 1st.

According to the Korea Exchange, as of 1:03 p.m. that day, Bukwang Pharmaceutical's share price was trading at 4,575 won, up 9.31% from the previous trading day.

At 12:13 p.m. that day, the static Volatility Interruption (VI) was triggered and lifted at 12:15 p.m. With the stock maintaining its strength even after the VI was lifted, attention is focused on whether the upward trend will continue until late in the session.

According to regulatory filings, Bukwang Pharmaceutical's main businesses include pharmaceuticals, health functional foods, and quasi-drug products, with major products including Dexid, Feroba, Latuda, Legalon, Thioc-Taside, and Thinzyroid.

Meanwhile, the KOSPI index, to which Bukwang Pharmaceutical belongs, was showing modest strength at the same time, drawing attention to the overall market trend.

[※ This article is for reference purposes only in making investment decisions, and responsibility for investments lies with the investor.]